Disruption of CSF-1R signaling inhibits growth of AML with inv(16)
Alexander Simonis(University of Cologne), Markus G. Manz(University of Zurich), C. Matthias Wilk(Icahn School of Medicine at Mount Sinai), Nicole Wildner-Verhey van Wijk(University of Zurich), Stefan Balabanov(University Medical Center Hamburg-Eppendorf), Mattheus H. E. Wildschut(ETH Zurich), Alexandre Theocharides(University of Zurich), Peter J.M. Valk(Erasmus MC), Norman F. Russkamp(University of Zurich), Jan Mueller(University of Zurich), Rouven Mueller(University of Zurich), Renier Myburgh(University of Zurich)
Cited by 9
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
PBX3 is an important cofactor of HOXA9 in leukemogenesis
|Blood|2012|170
Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19
|EMBO Molecular Medicine|2021|154